Molecular Partners AG

SWX:MOLN Stock Report

Market Cap: CHF 149.7m

Molecular Partners Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of MOLN?
Owner TypeNumber of SharesOwnership Percentage
Individual Insiders1,632,6864.43%
Public Companies1,739,1304.72%
General Public2,788,3237.56%
Institutions4,385,95111.9%
Hedge Funds26,317,00571.4%

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 12.2%.

Top Shareholders

Top 25 shareholders own 92.38% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
53.1%
BVF Partners L.P.
19,583,011CHF 79.5m125%3.03%
12.7%
Suvretta Capital Management, LLC
4,684,806CHF 19.0m168%0.85%
5.56%
EcoR1 Capital, LLC
2,049,188CHF 8.3m0%0.35%
5.24%
UBS Asset Management AG
1,932,920CHF 7.8m0.09%no data
4.72%
Novartis AG
1,739,130CHF 7.1m0%no data
2.79%
GAM Holding AG
1,027,810CHF 4.2m0%0.07%
2.08%
Michael Stumpp
767,524CHF 3.1m0%no data
1.99%
Patrick Amstutz
735,095CHF 3.0m0%no data
1.15%
Union Bancaire Privee, CBI-TDB, Asset Management Arm
425,615CHF 1.7m0.04%0.05%
0.59%
ZKB Asset Management
217,950CHF 884.9k28.4%no data
0.54%
Acatis Anlageberatung fur Investmentfonds GmbH
200,000CHF 812.0k0%0.07%
0.34%
Fourton Fund Management Co. Ltd
123,946CHF 503.2k0%0.24%
0.33%
Zürcher Kantonalbank, Investment Arm
122,369CHF 496.8k0%0.01%
0.28%
Pictet Asset Management SA
103,843CHF 421.6k2.66%no data
0.22%
BlackRock, Inc.
80,825CHF 328.2k1.62%no data
0.19%
BCV Asset Management
70,000CHF 284.2k0%0.01%
0.11%
Migrosbank Asset Management
41,529CHF 168.6k0%0.01%
0.079%
Nicolas Leupin
29,168CHF 118.4k0%no data
0.073%
William A. Burns
26,951CHF 109.4k0%no data
0.07%
Alexander Zurcher
25,706CHF 104.4k0%no data
0.062%
Renate Gloggner
23,006CHF 93.4k0%no data
0.04%
Steven H. Holtzman
14,717CHF 59.7k0%no data
0.035%
Baloise Asset Management
12,798CHF 52.0k-9.36%no data
0.032%
Dimensional Fund Advisors LP
11,792CHF 47.9k0.27%no data
0.017%
SEI Investments Management Corporation
6,087CHF 24.7k0%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/01 09:05
End of Day Share Price 2024/12/30 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Molecular Partners AG is covered by 14 analysts. 3 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Maurizio BernasconiBank am Bellevue
null nullCredit Suisse
Thomas KaufmannCredit Suisse